Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. has participated in 1 clinical trials.
Therapeutic areas: Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. has 1 clinical trials on record. Their work covers Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor.
Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.